newsfilter
← Latest News
GlobeNewswire·

ContraFect Reports Second Quarter 2021 Financial Results and Provides Business Update

Multiple peer-reviewed journal publications and presentations at scientific forums drive value and recognition across the Company's DLA portfolio Continued patient enrollment in ongoing Phase 3 DISRUPT study of exebacase YON